AK
Ashish Kintali
About Ashish Kintali
Data last updated:
Ashish Kintali is a Director at Barsana Pharma Private Limited (since 2024) and Director at Afford Jewels By Kintali's Private Limited (since 2020). The companies operate in Chemicals and Materials and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹9.64 Cr; the largest is Barsana Pharma Private Limited at ₹9.25 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Mar 2024 | 2009 | ₹9.25 Cr (FY 2023) | Active | |
| Director | 20 Nov 2020 | 2016 | ₹38.7 Lakh (FY 2017) | Active |
Board colleagues of Ashish Kintali
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akhil Kintali | 08966814 | Barsana Pharma Private Limited , Afford Jewels By Kintali's Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashish Kintali
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashish Kintali
Ashish Kintali currently holds 2 directorships: Barsana Pharma Private Limited (Director, since 01 Mar 2024, revenue ₹9.25 Cr (FY 2023)); Afford Jewels By Kintali's Private Limited (Director, since 20 Nov 2020, revenue ₹38.7 Lakh (FY 2017)).
Ashish Kintali was first appointed on 20 Nov 2020 as Director at Afford Jewels By Kintali's Private Limited. The most recent appointment on record is 01 Mar 2024 at Barsana Pharma Private Limited.
The 2 current companies of Ashish Kintali that report revenue have a combined latest revenue of ₹9.64 Cr: Barsana Pharma Private Limited ₹9.25 Cr (FY 2023); Afford Jewels By Kintali's Private Limited ₹38.7 Lakh (FY 2017).
The current boards of Ashish Kintali's companies include Akhil Kintali (Barsana Pharma Private Limited).